US drugmaker Eli Lilly has agreed a deal to purchase Loxo Oncology for $8bn, a move that will help the firm expand its capabilities in precision cancer treatments
The sale of Shire’s oncology business to unlisted French pharmaceutical company Servier has complicated Takeda Pharmaceutical’s bid to take over Shire
The China Food and Drink Administration will review a new drug developed by Chi-Med as possible cancer treatment
New technology has been forward that claims to be able to directly target cancer cells
